Found: 19
Select item for more details and to access through your institution.
Correction to: Afatinib is active in osteosarcoma cell lines.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Afatinib is active in osteosarcoma in osteosarcoma cell lines.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 7, p. 1693, doi. 10.1007/s00432-020-03220-y
- By:
- Publication type:
- Article
Non-reproducible sequence artifacts in FFPE tissue: an experience report.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 7, p. 1199, doi. 10.1007/s00432-017-2399-1
- By:
- Publication type:
- Article
A Neoadjuvant, Randomized, Open-Label Phase II Trial of Afatinib Versus Trastuzumab Versus Lapatinib in Patients With Locally Advanced HER2-Positive Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 2, p. 101, doi. 10.1016/j.clbc.2014.11.004
- By:
- Publication type:
- Article
Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 3, p. 218, doi. 10.1002/emmm.201100201
- By:
- Publication type:
- Article
Receptors for Melanocyte-Stimulating Hormone on Melanoma Cells<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1993, v. 680, n. 1, p. 320, doi. 10.1111/j.1749-6632.1993.tb19693.x
- By:
- Publication type:
- Article
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919897546
- By:
- Publication type:
- Article
Tyrosine phosphatase SHP-1 immunoreactivity increases in a subset of astrocytes following deafferentation of the chicken auditory brainstem.
- Published in:
- Journal of Comparative Neurology, 2000, v. 421, n. 2, p. 199, doi. 10.1002/(SICI)1096-9861(20000529)421:2<199::AID-CNE6>3.0.CO;2-G
- By:
- Publication type:
- Article
A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2014, v. 387, n. 6, p. 505, doi. 10.1007/s00210-014-0967-3
- By:
- Publication type:
- Article
Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.593852
- By:
- Publication type:
- Article
Combination of EGFR/HER2 Tyrosine Kinase Inhibition by BIBW 2992 and BIBW 2669 with Irradiation in FaDu Human Squamous Cell Carcinoma.
- Published in:
- Strahlentherapie und Onkologie, 2007, v. 183, n. 5, p. 256
- By:
- Publication type:
- Article
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 3, p. 908, doi. 10.3892/ijo.2016.3320
- By:
- Publication type:
- Article
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 434, doi. 10.1038/s41416-023-02513-6
- By:
- Publication type:
- Article
Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 1, p. 1, doi. 10.1002/pbc.29316
- By:
- Publication type:
- Article
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Therapeutic Potential of Afatinib in NRG1 Fusion‐Driven Solid Tumors: A Case Series.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 7, doi. 10.1634/theoncologist.2020-0379
- By:
- Publication type:
- Article
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.834704
- By:
- Publication type:
- Article
Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 367, doi. 10.2147/OTT.S346725
- By:
- Publication type:
- Article